TABLE 9. Incidence rates* and percentages† of invasive kidney and renal pelvis cancers, by demographic and tumor characteristics — United States,§ 2010–2014.
| Demographic characteristic | Total |
Male |
Female |
|||
|---|---|---|---|---|---|---|
| No. | Rate (95% CI) | No. | Rate (95% CI) | No. | Rate (95% CI) | |
|
Total
|
280,883
|
16.1 (16.1–16.2)
|
176,108
|
21.8 (21.7–21.9)
|
104,775
|
11.3 (11.2–11.4)
|
|
Age group at diagnosis (yrs)
| ||||||
| <40 |
13,898 |
1.8 (1.8–1.8) |
7,650 |
2.0 (1.9–2.0) |
6,248 |
1.6 (1.6–1.7) |
| 40–49 |
27,897 |
13.0 (12.8–13.1) |
17,920 |
16.8 (16.5–17.0) |
9,977 |
9.2 (9.0–9.4) |
| 50–59 |
61,403 |
28.2 (28.0–28.4) |
40,198 |
37.9 (37.5–38.2) |
21,205 |
19.0 (18.7–19.3) |
| 60–69 |
81,318 |
52.2 (51.9–52.6) |
53,099 |
71.8 (71.1–72.4) |
28,219 |
34.6 (34.2–35.0) |
| 70–79 |
61,763 |
70.5 (70.0–71.1) |
38,439 |
97.5 (96.5–98.5) |
23,324 |
48.5 (47.9–49.1) |
| ≥80 |
34,604 |
60.5 (59.9–61.1) |
18,802 |
87.8 (86.5–89.1) |
15,802 |
44.1 (43.4–44.8) |
|
Race
| ||||||
| White |
236,281 |
16.3 (16.2–16.3) |
148,897 |
21.9 (21.8–22.0) |
87,384 |
11.4 (11.3–11.5) |
| Black |
33,396 |
17.6 (17.4–17.8) |
20,108 |
24.2 (23.8–24.5) |
13,288 |
12.6 (12.4–12.8) |
| American Indian/Alaska Native |
2,526 |
15.7 (15.1–16.4) |
1,510 |
20.1 (19.0–21.3) |
1,016 |
11.9 (11.2–12.7) |
| Asian/Pacific Islander |
6,057 |
7.5 (7.3–7.7) |
3,926 |
10.9 (10.5–11.2) |
2,131 |
4.8 (4.6–5.1) |
|
Ethnicity¶
| ||||||
| Hispanic |
27,057 |
16.0 (15.8–16.2) |
16,067 |
20.8 (20.4–21.1) |
10,990 |
12.1 (11.8–12.3) |
| Non-Hispanic |
253,801 |
16.2 (16.1–16.3) |
160,031 |
22.0 (21.9–22.1) |
93,770 |
11.2 (11.2–11.3) |
|
County classification
| ||||||
| Metropolitan |
226,032 |
15.9 (15.9–16.0) |
141,835 |
21.7 (21.6–21.8) |
84,197 |
11.1 (11.0–11.2) |
| Nonmetropolitan |
41,830 |
17.1 (16.9–17.2) |
25,957 |
22.2 (21.9–22.5) |
15,873 |
12.5 (12.3–12.7) |
|
Census region
| ||||||
| Northeast |
52,819 |
16.1 (16.0–16.3) |
33,417 |
22.3 (22.1–22.6) |
19,402 |
10.9 (10.8–11.1) |
| Midwest |
65,551 |
17.1 (16.9–17.2) |
40,907 |
22.9 (22.7–23.1) |
24,644 |
12.1 (11.9–12.2) |
| South |
108,341 |
16.6 (16.5–16.7) |
67,177 |
22.2 (22.1–22.4) |
41,164 |
11.8 (11.7–11.9) |
| West |
54,172 |
14.5 (14.3–14.6) |
34,607 |
19.7 (19.5–19.9) |
19,565 |
9.9 (9.8–10.1) |
|
Tumor characteristic**
|
No.
|
%
|
No.
|
%
|
No.
|
%
|
|
Total
|
251,844
|
100.0
|
158,949
|
100.0
|
92,895
|
100.0
|
|
Histology
| ||||||
| Renal cell carcinoma |
221,417 |
87.9 |
140,989 |
88.7 |
80,428 |
86.6 |
| Other adenocarcinomas |
6,286 |
2.5 |
4,060 |
2.6 |
2,226 |
2.4 |
| Transitional cell carcinoma |
16,767 |
6.7 |
9,805 |
6.2 |
6,962 |
7.5 |
| Epithelial carcinoma, NOS |
1,942 |
0.8 |
1,217 |
0.8 |
725 |
0.8 |
| All other histologies |
5,432 |
2.2 |
2,878 |
1.8 |
2,554 |
2.7 |
|
Stage††
| ||||||
| Localized |
169,202 |
67.2 |
104,164 |
65.5 |
65,038 |
70.0 |
| Regional |
42,681 |
16.9 |
28,202 |
17.7 |
14,479 |
15.6 |
| Distant |
34,681 |
13.8 |
23,306 |
14.7 |
11,375 |
12.2 |
| Unknown | 5,280 | 2.1 | 3,277 | 2.1 | 2,003 | 2.2 |
Abbreviations: CI = confidence interval; NOS = not otherwise specified.
* New cases diagnosed per 100,000 persons, age adjusted to the 2000 U.S. standard population.
† New cases diagnosed.
§ Cancer incidence data were compiled from cancer registries that met the data quality criteria for all invasive cancer sites combined, representing approximately 99% of the U.S. population. (Data from Nevada did not meet U.S. Cancer Statistics publication criteria for 2010–2014.)
¶ Ethnicity is not mutually exclusive from race.
** Only includes microscopically confirmed cases; excludes cases identified only through death certificate or autopsy report.
†† Localized: cancer that is confined to the primary site; regional: cancer that has spread directly beyond the primary site or to regional lymph nodes; distant: cancer that has spread to other organs.